Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Title:Acknowledgements to Reviewers:
Volume: 13 Issue: 3
Export Options
About this article
Cite this article as:
Acknowledgements to Reviewers:, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2014; 13 (3) . https://dx.doi.org/10.2174/187152301303150120170601
DOI https://dx.doi.org/10.2174/187152301303150120170601 |
Print ISSN 1871-5230 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-614X |
22
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Microglia in Alzheimer’s Disease
Current Alzheimer Research Clinical Trial Update and Novel Therapeutic Approaches for Metastatic Prostate Cancer
Current Medicinal Chemistry Clinical Trials for Acute Kidney Injury: Design Challenges and Possible Solutions
Current Drug Targets Cannabis-Derived Substances in Cancer Therapy – An Emerging Anti- Inflammatory Role for the Cannabinoids
Current Clinical Pharmacology Naturally Occurring and Synthetic Agents as Potential Anti-Inflammatory and Immunomodulants
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry The Potential and Limitations of p38MAPK as a Drug Target for the Treatment of Hematological Malignancies
Current Drug Targets Methodological Problems in RCTs on IBD
Reviews on Recent Clinical Trials Targeting Stress Activated Protein Kinases, JNK and p38, as New Therapeutic Approach for Neurodegenerative Diseases
Central Nervous System Agents in Medicinal Chemistry Regulation of Dendritic Cell Function Through Toll-Like Receptors
Current Molecular Medicine The Endothelium and Platelets in Cardiovascular Disease: Potential Targets for Therapeutic Intervention
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Resistant Hypertension in the Elderly-Second Line Treatments: Aldosterone Antagonists, Central Alpha-Agonist Agents, Alpha-Adrenergic Receptor Blockers, Direct Vasodilators, and Exogenous Nitric Oxide Donors
Cardiovascular & Hematological Agents in Medicinal Chemistry Novel Therapies for Asthma - Advances and Problems
Current Pharmaceutical Design Editorial [Hot Topic: Emerging Strategies for Allergen Specific Immunotherapy (Guest Editors: Prem L. Bhalla & Mohan B. Singh)]
Inflammation & Allergy - Drug Targets (Discontinued) HSP27 Protects the Blood-Brain Barrier Against Ischemia-Induced Loss of Integrity
CNS & Neurological Disorders - Drug Targets Prospects for Plant-Derived Chemopreventive Agents Exhibiting Multiple Mechanisms of Action
Current Medicinal Chemistry - Anti-Cancer Agents Genetic Polymorphisms of ATP-Binding Cassette Transporters ABCB1 and ABCC2 and their Impact on Drug Disposition
Current Drug Targets The Optimal Route of Administration of the Glycoprotein IIb/IIIa Receptor Antagonist Abciximab During Percutaneous Coronary Intervention; Intravenous Versus Intracoronary
Current Cardiology Reviews Opioids Resistance in Chronic Pain Management
Current Neuropharmacology The Role of High Mobility Group Box 1 (HMGB1) in Neurodegeneration: A Systematic Review
Current Neuropharmacology Mushrooms as a Source of Anti-Inflammatory Agents
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry